Linner Nova Earbud vs Otofonix Groove

The Linner Nova Earbud is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.5/5 in our lab testing. Priced at $299, this visible-in-ear device offers an interesting performance profile that sets it apart from typical hearing aids in its category. The Nova Earbud's standout strength is its excellent music streaming quality, scoring 4.5/5—a full 2.58 points above the OTC category average. This makes it one of the better options for users who prioritize audio entertainment through their hearing devices. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without the whistling that plagues some competitors. However, the device shows significant limitations in core hearing aid functions. Speech in quiet environments scores a mixed 2.1/5, falling 0.71 points below the category average. Speech in noise performance is low at 1.3/5, slightly below average for the category. Own-voice comfort is notably weak at 0.5/5, sitting 2.01 points below the category average—users may find their own voice sounds unnatural or boomy. The Linner Nova Earbud is best suited for budget-conscious consumers who value music streaming and stable feedback performance over maximum speech clarity. Those prioritizing speech understanding, particularly in noisy environments, may want to consider alternatives like the higher-scoring Elehear Beyond or Apple AirPods Pro 2 in the same price range.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.